JULIE TURNER: Open Payments
NPI 1922426519 · ATCHISON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 14 payments from 9 companies in 2025. Trend: 2023 $59 · 2024 $58 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $80 |
| Aimmune Therapeutics, Inc. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $31 |
| Madrigal Pharmaceuticals | 1 | $26 |
| PFIZER INC. | 1 | $19 |
| Celltrion USA Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: ENTYVIO, ZENPEP, TREMFYA, REZDIFFRA, RINVOQ, VRAYLAR, VELSIPITY, VEGZELMA.
Industry payments across KS — which companies pay providers there.
